Real-World Data Collection Regarding Titration Algorithms for Insulin Glargine in Patients With Type 2 Diabetes Mellitus
In conclusion, the insulin glargine TAs delivered safe dose recommendations with a low risk of hypoglycemia, which successfully led to a stable dose in the vast majority of patients.
Source: Journal of Diabetes Science and Technology - Category: Endocrinology Authors: Pfützner, A., Stratmann, B., Funke, K., Pohlmeier, H., Rose, L., Sieber, J., Flacke, F., Tschoepe, D. Tags: Original Articles Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Insulin | Lantus | Science | Study | Women